Diseases · Entity Annotation Prototype (beta)

1articles mentioning diseases

2disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: 1L NSCLC ×

1L NSCLC

This disease is selected. Its supporting articles are shown below.

1L NSCLC1

Articles mentioning 1L NSCLC

1 articles · page 1 of 1

1310 A phase 1/IIa study of ILKN421H, a LNP mRNA encoding an IL2Rβγ selective IL-2v, as monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors

jitc · abstract · 2025-11-07 · 2 matching annotations

82.8%

advanced solid tumors 1L NSCLC ILKN421H pembrolizumab

…cacy of ILKN421H with or without pembrolizumab in patients with advanced solid tumors. The design includes two portions of the study: Parts A, ILKN42…

Browse diseases

1L NSCLC

Articles mentioning 1L NSCLC

1310 A phase 1/IIa study of ILKN421H, a LNP mRNA encoding an IL2Rβγ selective IL-2v, as monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors